We observed clonal induction of hepatocytes, which evolved over time into microscopic lesions and then macroscopic tumour nodules, with glutamine synthetase (GS) as a marker of β-catenin driven tumour induction (Fig. 4a–c). Here, GLUL is linked to neoplasm.